| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 1.35e-08 | 25 | 63 | 5 | GO:0017056 | |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 1.50e-06 | 27 | 63 | 4 | GO:0008139 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 2.62e-06 | 279 | 63 | 8 | GO:0005096 | |
| GeneOntologyMolecularFunction | signal sequence binding | 2.01e-05 | 51 | 63 | 4 | GO:0005048 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 2.86e-05 | 507 | 63 | 9 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 2.86e-05 | 507 | 63 | 9 | GO:0030695 | |
| GeneOntologyMolecularFunction | enzyme activator activity | 2.05e-04 | 656 | 63 | 9 | GO:0008047 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | TCF4 ASXL1 TLE2 NSD1 MYOCD SORBS1 NUP62 ZZEF1 TRRAP NUP153 WWC1 MRTFA | 2.37e-04 | 1160 | 63 | 12 | GO:0030674 |
| GeneOntologyMolecularFunction | molecular adaptor activity | TCF4 ASXL1 TLE2 NSD1 MLLT3 MYOCD SORBS1 NUP62 ZZEF1 TRRAP NUP153 WWC1 MRTFA | 2.65e-04 | 1356 | 63 | 13 | GO:0060090 |
| GeneOntologyMolecularFunction | transcription coregulator activity | 3.72e-04 | 562 | 63 | 8 | GO:0003712 | |
| GeneOntologyMolecularFunction | chromatin binding | 4.90e-04 | 739 | 63 | 9 | GO:0003682 | |
| GeneOntologyBiologicalProcess | nuclear export | 9.15e-08 | 185 | 63 | 8 | GO:0051168 | |
| GeneOntologyBiologicalProcess | RNA export from nucleus | 4.76e-07 | 96 | 63 | 6 | GO:0006405 | |
| GeneOntologyBiologicalProcess | activation of GTPase activity | 1.01e-06 | 109 | 63 | 6 | GO:0090630 | |
| GeneOntologyBiologicalProcess | nuclear transport | STRADB MCM3AP PTPN22 NUP62 NUP214 POM121C POM121B ADAR NUP153 | 2.10e-06 | 378 | 63 | 9 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | STRADB MCM3AP PTPN22 NUP62 NUP214 POM121C POM121B ADAR NUP153 | 2.10e-06 | 378 | 63 | 9 | GO:0006913 |
| GeneOntologyBiologicalProcess | protein import into nucleus | 2.14e-06 | 195 | 63 | 7 | GO:0006606 | |
| GeneOntologyBiologicalProcess | import into nucleus | 2.62e-06 | 201 | 63 | 7 | GO:0051170 | |
| GeneOntologyBiologicalProcess | mRNA transport | 5.32e-06 | 145 | 63 | 6 | GO:0051028 | |
| GeneOntologyBiologicalProcess | RNA transport | 1.56e-05 | 175 | 63 | 6 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 1.56e-05 | 175 | 63 | 6 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 1.72e-05 | 178 | 63 | 6 | GO:0051236 | |
| GeneOntologyBiologicalProcess | nuclear pore organization | 2.14e-05 | 18 | 63 | 3 | GO:0006999 | |
| GeneOntologyBiologicalProcess | RNA localization | 5.22e-05 | 217 | 63 | 6 | GO:0006403 | |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | 7.10e-05 | 335 | 63 | 7 | GO:0043087 | |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | 9.97e-05 | 244 | 63 | 6 | GO:0043547 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 1.11e-04 | 249 | 63 | 6 | GO:0015931 | |
| GeneOntologyBiologicalProcess | negative regulation of protein localization to plasma membrane | 1.15e-04 | 31 | 63 | 3 | GO:1903077 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | 1.15e-04 | 362 | 63 | 7 | GO:0034504 | |
| GeneOntologyBiologicalProcess | negative regulation of protein localization to cell periphery | 1.39e-04 | 33 | 63 | 3 | GO:1904376 | |
| GeneOntologyBiologicalProcess | negative regulation of protein localization to membrane | 2.66e-04 | 41 | 63 | 3 | GO:1905476 | |
| GeneOntologyBiologicalProcess | neuroblast proliferation | 2.89e-04 | 104 | 63 | 4 | GO:0007405 | |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | TBC1D4 DLC1 SIPA1L1 VCAN TBCK AGAP4 AGAP6 USP6NL MRTFA SH3BP4 | 3.06e-04 | 878 | 63 | 10 | GO:0051336 |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | 5.30e-04 | 333 | 63 | 6 | GO:0051056 | |
| GeneOntologyBiologicalProcess | negative regulation of protein kinase activity | 5.72e-04 | 221 | 63 | 5 | GO:0006469 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to plasma membrane | 6.35e-04 | 128 | 63 | 4 | GO:1903076 | |
| GeneOntologyBiologicalProcess | negative regulation of kinase activity | 7.70e-04 | 236 | 63 | 5 | GO:0033673 | |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | 7.98e-04 | 499 | 63 | 7 | GO:0051345 | |
| GeneOntologyCellularComponent | nuclear pore | 5.95e-07 | 101 | 63 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | TCF4 ASXL1 ATXN7 MCM3AP NSD1 MLLT3 MYOCD NUP62 NUP214 POM121C MGA POM121B TRRAP ADAR NUP153 | 1.07e-05 | 1377 | 63 | 15 | GO:0140513 |
| GeneOntologyCellularComponent | Golgi lumen | 1.94e-05 | 109 | 63 | 5 | GO:0005796 | |
| GeneOntologyCellularComponent | nuclear membrane | 6.33e-04 | 349 | 63 | 6 | GO:0031965 | |
| GeneOntologyCellularComponent | annulate lamellae | 7.95e-04 | 14 | 63 | 2 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 1.33e-03 | 18 | 63 | 2 | GO:0044615 | |
| GeneOntologyCellularComponent | transcription factor TFTC complex | 1.33e-03 | 18 | 63 | 2 | GO:0033276 | |
| GeneOntologyCellularComponent | nuclear envelope | 1.44e-03 | 560 | 63 | 7 | GO:0005635 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 1.82e-03 | 80 | 63 | 3 | GO:0005905 | |
| GeneOntologyCellularComponent | inclusion body | 2.54e-03 | 90 | 63 | 3 | GO:0016234 | |
| GeneOntologyCellularComponent | SAGA complex | 2.56e-03 | 25 | 63 | 2 | GO:0000124 | |
| Domain | RPEL | 2.11e-04 | 7 | 60 | 2 | PS51073 | |
| Domain | RPEL | 2.11e-04 | 7 | 60 | 2 | PF02755 | |
| Domain | RPEL | 2.11e-04 | 7 | 60 | 2 | SM00707 | |
| Domain | RPEL_repeat | 2.11e-04 | 7 | 60 | 2 | IPR004018 | |
| Domain | TBC | 5.23e-04 | 49 | 60 | 3 | SM00164 | |
| Domain | TIL | 6.56e-04 | 12 | 60 | 2 | PF01826 | |
| Domain | C8 | 6.56e-04 | 12 | 60 | 2 | PF08742 | |
| Domain | RabGAP-TBC | 6.59e-04 | 53 | 60 | 3 | PF00566 | |
| Domain | TBC_RABGAP | 7.34e-04 | 55 | 60 | 3 | PS50086 | |
| Domain | Rab-GTPase-TBC_dom | 7.34e-04 | 55 | 60 | 3 | IPR000195 | |
| Domain | Unchr_dom_Cys-rich | 7.74e-04 | 13 | 60 | 2 | IPR014853 | |
| Domain | C8 | 7.74e-04 | 13 | 60 | 2 | SM00832 | |
| Domain | SEA | 9.01e-04 | 14 | 60 | 2 | SM00200 | |
| Domain | TIL_dom | 9.01e-04 | 14 | 60 | 2 | IPR002919 | |
| Domain | VWD | 1.18e-03 | 16 | 60 | 2 | SM00216 | |
| Domain | VWF_type-D | 1.18e-03 | 16 | 60 | 2 | IPR001846 | |
| Domain | VWFD | 1.18e-03 | 16 | 60 | 2 | PS51233 | |
| Domain | VWD | 1.18e-03 | 16 | 60 | 2 | PF00094 | |
| Domain | - | 1.56e-03 | 391 | 60 | 6 | 2.30.29.30 | |
| Domain | VWC_out | 1.68e-03 | 19 | 60 | 2 | SM00215 | |
| Domain | PH | 1.97e-03 | 278 | 60 | 5 | SM00233 | |
| Domain | PH_domain | 2.04e-03 | 280 | 60 | 5 | IPR001849 | |
| Domain | - | 2.05e-03 | 21 | 60 | 2 | 1.10.720.30 | |
| Domain | CT | 2.25e-03 | 22 | 60 | 2 | SM00041 | |
| Domain | SAP | 2.25e-03 | 22 | 60 | 2 | PF02037 | |
| Domain | PH_dom-like | 2.41e-03 | 426 | 60 | 6 | IPR011993 | |
| Domain | SAP | 2.46e-03 | 23 | 60 | 2 | SM00513 | |
| Domain | SEA | 2.46e-03 | 23 | 60 | 2 | PS50024 | |
| Domain | SEA_dom | 2.46e-03 | 23 | 60 | 2 | IPR000082 | |
| Domain | SAP | 2.90e-03 | 25 | 60 | 2 | PS50800 | |
| Domain | Cys_knot_C | 2.90e-03 | 25 | 60 | 2 | IPR006207 | |
| Domain | SAP_dom | 2.90e-03 | 25 | 60 | 2 | IPR003034 | |
| Domain | CTCK_2 | 2.90e-03 | 25 | 60 | 2 | PS01225 | |
| Domain | Znf_PHD | 3.13e-03 | 91 | 60 | 3 | IPR001965 | |
| Domain | ZF_PHD_2 | 3.54e-03 | 95 | 60 | 3 | PS50016 | |
| Domain | PID | 3.64e-03 | 28 | 60 | 2 | PF00640 | |
| Domain | ZF_PHD_1 | 3.64e-03 | 96 | 60 | 3 | PS01359 | |
| Domain | ArfGap | 3.90e-03 | 29 | 60 | 2 | SM00105 | |
| Domain | ArfGap | 3.90e-03 | 29 | 60 | 2 | PF01412 | |
| Domain | ARFGAP | 3.90e-03 | 29 | 60 | 2 | PS50115 | |
| Domain | ArfGAP | 3.90e-03 | 29 | 60 | 2 | IPR001164 | |
| Domain | PID | 4.73e-03 | 32 | 60 | 2 | PS01179 | |
| Domain | HLH | 6.18e-03 | 116 | 60 | 3 | SM00353 | |
| Domain | PTB | 7.32e-03 | 40 | 60 | 2 | SM00462 | |
| Domain | PTB/PI_dom | 7.68e-03 | 41 | 60 | 2 | IPR006020 | |
| Domain | VWF_dom | 8.05e-03 | 42 | 60 | 2 | IPR001007 | |
| Domain | ANK_REPEAT | 8.86e-03 | 253 | 60 | 4 | PS50088 | |
| Domain | ANK_REP_REGION | 8.98e-03 | 254 | 60 | 4 | PS50297 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 1.75e-07 | 16 | 46 | 4 | M27410 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.79e-07 | 40 | 46 | 5 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 2.03e-07 | 41 | 46 | 5 | MM15200 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 2.29e-07 | 17 | 46 | 4 | M27412 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 2.30e-07 | 42 | 46 | 5 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 2.60e-07 | 43 | 46 | 5 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 4.10e-07 | 47 | 46 | 5 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 5.07e-07 | 49 | 46 | 5 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 5.62e-07 | 50 | 46 | 5 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 6.21e-07 | 51 | 46 | 5 | MM15151 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 8.40e-07 | 23 | 46 | 4 | M556 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 9.11e-07 | 55 | 46 | 5 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 1.19e-06 | 58 | 46 | 5 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 1.19e-06 | 58 | 46 | 5 | MM14736 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 1.41e-06 | 26 | 46 | 4 | M27483 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 2.11e-06 | 65 | 46 | 5 | MM15147 | |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | 3.34e-06 | 32 | 46 | 4 | M29579 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 3.77e-06 | 73 | 46 | 5 | MM14948 | |
| Pathway | REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS | 3.79e-06 | 33 | 46 | 4 | M27016 | |
| Pathway | REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN | 4.28e-06 | 34 | 46 | 4 | M27041 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 4.82e-06 | 35 | 46 | 4 | M27320 | |
| Pathway | BIOCARTA_NPC_PATHWAY | 5.27e-06 | 11 | 46 | 3 | M22033 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 5.41e-06 | 36 | 46 | 4 | M27245 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 5.41e-06 | 36 | 46 | 4 | M26974 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 6.06e-06 | 37 | 46 | 4 | M1029 | |
| Pathway | REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS | 6.06e-06 | 37 | 46 | 4 | M27038 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 6.69e-06 | 82 | 46 | 5 | MM15394 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 7.51e-06 | 39 | 46 | 4 | M27238 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 7.54e-06 | 84 | 46 | 5 | MM14929 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 8.46e-06 | 86 | 46 | 5 | MM15413 | |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 9.20e-06 | 41 | 46 | 4 | M29574 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.12e-05 | 43 | 46 | 4 | M26975 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 1.18e-05 | 92 | 46 | 5 | MM14951 | |
| Pathway | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | 1.22e-05 | 44 | 46 | 4 | M109 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.46e-05 | 46 | 46 | 4 | M27397 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 1.60e-05 | 47 | 46 | 4 | M27395 | |
| Pathway | REACTOME_SUMOYLATION | 1.71e-05 | 169 | 46 | 6 | MM14919 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 2.58e-05 | 53 | 46 | 4 | M27212 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 2.78e-05 | 54 | 46 | 4 | M29594 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 3.33e-05 | 114 | 46 | 5 | MM15361 | |
| Pathway | REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS | 3.96e-05 | 59 | 46 | 4 | M27606 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 4.15e-05 | 21 | 46 | 3 | MM15706 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 4.82e-05 | 62 | 46 | 4 | M546 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 6.94e-05 | 68 | 46 | 4 | M27303 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 8.22e-05 | 71 | 46 | 4 | M27394 | |
| Pathway | REACTOME_ISG15_ANTIVIRAL_MECHANISM | 9.66e-05 | 74 | 46 | 4 | M48006 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 9.82e-05 | 143 | 46 | 5 | M27275 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.13e-04 | 77 | 46 | 4 | M27226 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 1.27e-04 | 151 | 46 | 5 | M550 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 1.31e-04 | 80 | 46 | 4 | M223 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 1.44e-04 | 82 | 46 | 4 | M27250 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.58e-04 | 84 | 46 | 4 | M725 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.66e-04 | 85 | 46 | 4 | M1870 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 2.35e-04 | 271 | 46 | 6 | MM15406 | |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 2.98e-04 | 99 | 46 | 4 | M27474 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 3.22e-04 | 101 | 46 | 4 | M27253 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | ASXL1 ATXN7 VCAN MUC16 MUC5B NUP62 NUP214 POM121C POM121B TRRAP MUC6 NUP153 MRTFA | 3.55e-04 | 1389 | 46 | 13 | MM15307 |
| Pathway | REACTOME_SUMOYLATION | 3.61e-04 | 189 | 46 | 5 | M27214 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 3.87e-04 | 106 | 46 | 4 | M27458 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 4.61e-04 | 111 | 46 | 4 | M27416 | |
| Pathway | REACTOME_TRNA_PROCESSING | 4.61e-04 | 111 | 46 | 4 | M27684 | |
| Pathway | REACTOME_HCMV_LATE_EVENTS | 5.44e-04 | 116 | 46 | 4 | M29806 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | ASXL1 ATXN7 VCAN MUC16 MUC5B NUP62 NUP214 POM121C TRRAP MUC3A MUC6 NUP153 MRTFA | 6.36e-04 | 1475 | 46 | 13 | M19806 |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 7.43e-04 | 126 | 46 | 4 | M45009 | |
| Pathway | REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS | 8.59e-04 | 131 | 46 | 4 | M5283 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 9.77e-04 | 60 | 46 | 3 | MM15636 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 1.04e-03 | 138 | 46 | 4 | M29805 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 1.07e-03 | 139 | 46 | 4 | M715 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 1.10e-03 | 140 | 46 | 4 | M27484 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | 1.16e-03 | 505 | 46 | 7 | MM15548 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 1.16e-03 | 142 | 46 | 4 | M27660 | |
| Pathway | PID_SMAD2_3PATHWAY | 1.21e-03 | 16 | 46 | 2 | M228 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 1.28e-03 | 250 | 46 | 5 | M27554 | |
| Pathway | REACTOME_HIV_LIFE_CYCLE | 1.39e-03 | 149 | 46 | 4 | M4076 | |
| Pathway | REACTOME_INFLUENZA_INFECTION | 1.68e-03 | 157 | 46 | 4 | M4669 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 1.88e-03 | 273 | 46 | 5 | M983 | |
| Pathway | REACTOME_HCMV_INFECTION | 1.88e-03 | 162 | 46 | 4 | M29804 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 2.00e-03 | 277 | 46 | 5 | MM15414 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 2.37e-03 | 288 | 46 | 5 | M16864 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 2.60e-03 | 177 | 46 | 4 | M27476 | |
| Pathway | REACTOME_MYOGENESIS | 2.75e-03 | 24 | 46 | 2 | MM15174 | |
| Pathway | REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION | 2.75e-03 | 24 | 46 | 2 | MM15658 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 3.22e-03 | 26 | 46 | 2 | MM14793 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 3.23e-03 | 91 | 46 | 3 | M27101 | |
| Pathway | REACTOME_MYOGENESIS | 4.00e-03 | 29 | 46 | 2 | M853 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NUCLEAR_EXPORT_OF_MRNA | 4.28e-03 | 30 | 46 | 2 | M47752 | |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | 4.32e-03 | 204 | 46 | 4 | M45011 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | 5.13e-03 | 1022 | 46 | 9 | MM15436 | |
| Pathway | WP_PRADERWILLI_AND_ANGELMAN_SYNDROME | 5.36e-03 | 109 | 46 | 3 | M39542 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 5.36e-03 | 109 | 46 | 3 | MM15164 | |
| Pathway | REACTOME_HIV_INFECTION | 6.69e-03 | 231 | 46 | 4 | M12469 | |
| Pathway | REACTOME_M_PHASE | 8.27e-03 | 387 | 46 | 5 | MM15364 | |
| Pathway | PID_P53_DOWNSTREAM_PATHWAY | 1.00e-02 | 137 | 46 | 3 | M145 | |
| Pathway | WP_RETT_SYNDROME | 1.07e-02 | 48 | 46 | 2 | M39759 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | NUMB PTPN22 NUP214 POM121C MGA TRIP12 PICALM WNK4 NUP153 MRTFA TP53BP2 SH3BP4 | 2.01e-11 | 430 | 64 | 12 | 35044719 |
| Pubmed | 5.33e-11 | 15 | 64 | 5 | 14697343 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TBC1D4 DLC1 TEX2 PHF3 SIPA1L1 NUMB SORBS1 NUP62 PPIP5K2 TRIP12 USP6NL WNK4 TP53BP2 SH3BP4 | 4.45e-10 | 861 | 64 | 14 | 36931259 |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 8.62e-09 | 38 | 64 | 5 | 12791264 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 3.13e-08 | 18 | 64 | 4 | 18834073 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | TCF4 DYM TEX2 SIPA1L1 SORBS1 PPIP5K2 AGAP4 AGAP6 WWC1 SH3BP4 | 5.00e-08 | 536 | 64 | 10 | 15840001 |
| Pubmed | TCF4 DYM TEX2 SIPA1L1 SORBS1 PPIP5K2 AGAP4 AGAP6 WWC1 SH3BP4 | 5.17e-08 | 538 | 64 | 10 | 10512203 | |
| Pubmed | 5.93e-08 | 5 | 64 | 3 | 16730000 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 1.14e-07 | 440 | 64 | 9 | 34244565 | |
| Pubmed | 1.18e-07 | 6 | 64 | 3 | 19110483 | ||
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 1.58e-07 | 218 | 64 | 7 | 33378226 | |
| Pubmed | 2.07e-07 | 7 | 64 | 3 | 11238447 | ||
| Pubmed | Imaging within single NPCs reveals NXF1's role in mRNA export on the cytoplasmic side of the pore. | 3.31e-07 | 8 | 64 | 3 | 31375530 | |
| Pubmed | 3.51e-07 | 503 | 64 | 9 | 16964243 | ||
| Pubmed | 4.95e-07 | 9 | 64 | 3 | 9114010 | ||
| Pubmed | 7.07e-07 | 10 | 64 | 3 | 18596238 | ||
| Pubmed | 7.07e-07 | 10 | 64 | 3 | 19581287 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 8.74e-07 | 281 | 64 | 7 | 28706196 | |
| Pubmed | 9.06e-07 | 40 | 64 | 4 | 37516964 | ||
| Pubmed | 9.70e-07 | 11 | 64 | 3 | 23652018 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 1.03e-06 | 180 | 64 | 6 | 35198878 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TBC1D4 ATXN7 PHF3 SIPA1L1 NUP214 ARHGAP39 TRRAP TRIP12 NUP153 MRTFA | 1.44e-06 | 774 | 64 | 10 | 15302935 |
| Pubmed | 2.13e-06 | 14 | 64 | 3 | 11073998 | ||
| Pubmed | 2.46e-06 | 209 | 64 | 6 | 36779422 | ||
| Pubmed | 2.64e-06 | 332 | 64 | 7 | 25693804 | ||
| Pubmed | 3.06e-06 | 486 | 64 | 8 | 20936779 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 25410863 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 24418548 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 11371513 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 31928221 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 14970199 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 22558357 | ||
| Pubmed | Inhibition of nuclear import and alteration of nuclear pore complex composition by rhinovirus. | 3.33e-06 | 2 | 64 | 2 | 12163599 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 23892081 | ||
| Pubmed | 3.97e-06 | 17 | 64 | 3 | 10668806 | ||
| Pubmed | 4.31e-06 | 130 | 64 | 5 | 12421765 | ||
| Pubmed | 9.17e-06 | 263 | 64 | 6 | 34702444 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 22139079 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 17363709 | ||
| Pubmed | Interactions and three-dimensional localization of a group of nuclear pore complex proteins. | 9.99e-06 | 3 | 64 | 2 | 8045926 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 12191473 | ||
| Pubmed | POM121 inhibits the macrophage inflammatory response by impacting NF-κB P65 nuclear accumulation. | 9.99e-06 | 3 | 64 | 2 | 30802453 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 37289107 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 27230679 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 35507432 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 9847314 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 18025109 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 23103763 | ||
| Pubmed | The nuclear pore complex: a new dynamic in HIV-1 replication. | 9.99e-06 | 3 | 64 | 2 | 21327100 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 11439182 | ||
| Pubmed | Probing nuclear pore complex architecture with proximity-dependent biotinylation. | 1.28e-05 | 77 | 64 | 4 | 24927568 | |
| Pubmed | 1.33e-05 | 25 | 64 | 3 | 10601273 | ||
| Pubmed | 1.42e-05 | 430 | 64 | 7 | 32581705 | ||
| Pubmed | TMTC3 TEX2 SIPA1L1 MCM3AP NUMB NUP62 NUP214 POM121C PICALM USP6NL | 1.45e-05 | 1007 | 64 | 10 | 34597346 | |
| Pubmed | 1.50e-05 | 26 | 64 | 3 | 12228227 | ||
| Pubmed | TBC1D4 PHF3 SIPA1L1 MLLT3 NUP214 PLEKHA6 MGA TRIP12 WWC1 TP53BP2 SH3BP4 | 1.57e-05 | 1247 | 64 | 11 | 27684187 | |
| Pubmed | LINC01600 DLC1 SIPA1L1 PLEKHS1 PTPN22 SORBS1 POM121C USP6NL NUP153 | 1.76e-05 | 814 | 64 | 9 | 23251661 | |
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 17471237 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 14984930 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 15522285 | ||
| Pubmed | Two distinct human POM121 genes: requirement for the formation of nuclear pore complexes. | 2.00e-05 | 4 | 64 | 2 | 17900573 | |
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | 2.00e-05 | 4 | 64 | 2 | 29869461 | |
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 21596555 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 17991879 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 30022050 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 23807779 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 24739174 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 12397177 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 27374225 | ||
| Pubmed | Biallelic mutations in nucleoporin NUP88 cause lethal fetal akinesia deformation sequence. | 2.00e-05 | 4 | 64 | 2 | 30543681 | |
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 12676567 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 16204380 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | TMTC3 PHF3 NSD1 NUP62 NUP214 POM121C MGA TRRAP ADAR TRIP12 NUP153 | 2.20e-05 | 1294 | 64 | 11 | 30804502 |
| Pubmed | Integrated structural analysis of the human nuclear pore complex scaffold. | 2.33e-05 | 30 | 64 | 3 | 24315095 | |
| Pubmed | 2.33e-05 | 30 | 64 | 3 | 27016207 | ||
| Pubmed | 2.60e-05 | 653 | 64 | 8 | 22586326 | ||
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 18945672 | ||
| Pubmed | Dynein Light Chain 1 (DYNLT1) Interacts with Normal and Oncogenic Nucleoporins. | 3.32e-05 | 5 | 64 | 2 | 23840580 | |
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 7603572 | ||
| Pubmed | Ran-binding protein 3 is a cofactor for Crm1-mediated nuclear protein export. | 3.32e-05 | 5 | 64 | 2 | 11425870 | |
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 16494529 | ||
| Pubmed | Muscle-specific signaling mechanism that links actin dynamics to serum response factor. | 3.32e-05 | 5 | 64 | 2 | 15798203 | |
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 24840470 | ||
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 12894213 | ||
| Pubmed | Distinct domain utilization by Smad3 and Smad4 for nucleoporin interaction and nuclear import. | 3.32e-05 | 5 | 64 | 2 | 12917407 | |
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 12138183 | ||
| Pubmed | Essential role of KIBRA in co-activator function of dynein light chain 1 in mammalian cells. | 3.32e-05 | 5 | 64 | 2 | 16684779 | |
| Pubmed | Exportin-5, a novel karyopherin, mediates nuclear export of double-stranded RNA binding proteins. | 3.32e-05 | 5 | 64 | 2 | 11777942 | |
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 19828735 | ||
| Pubmed | The nuclear pore complex: from molecular architecture to functional dynamics. | 3.32e-05 | 5 | 64 | 2 | 10395558 | |
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 17360478 | ||
| Pubmed | Nuclear pore composition regulates neural stem/progenitor cell differentiation in the mouse embryo. | 3.41e-05 | 34 | 64 | 3 | 18539113 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 3.59e-05 | 497 | 64 | 7 | 36774506 | |
| Pubmed | 4.34e-05 | 105 | 64 | 4 | 9628581 | ||
| Pubmed | 4.98e-05 | 6 | 64 | 2 | 7568168 | ||
| Pubmed | 4.98e-05 | 6 | 64 | 2 | 11266456 | ||
| Pubmed | Ataxin-7 is a subunit of GCN5 histone acetyltransferase-containing complexes. | 4.98e-05 | 6 | 64 | 2 | 15115762 | |
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 5.02e-05 | 109 | 64 | 4 | 33554859 | |
| Pubmed | 5.32e-05 | 529 | 64 | 7 | 14621295 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 6.03e-05 | 954 | 64 | 9 | 36373674 | |
| Interaction | PARD3 interactions | 4.49e-06 | 298 | 64 | 8 | int:PARD3 | |
| Interaction | YWHAG interactions | TBC1D4 DLC1 NHSL2 PHF3 SIPA1L1 NUMB SORBS1 NUP62 PPIP5K2 TRRAP TRIP12 USP6NL WWC1 TP53BP2 SH3BP4 | 6.24e-06 | 1248 | 64 | 15 | int:YWHAG |
| Interaction | YWHAH interactions | TBC1D4 NHSL2 TEX2 PHF3 SIPA1L1 NUMB SORBS1 NUP62 PPIP5K2 TRIP12 USP6NL WWC1 TP53BP2 SH3BP4 | 7.22e-06 | 1102 | 64 | 14 | int:YWHAH |
| Interaction | SYNE3 interactions | TMTC3 TEX2 SIPA1L1 SORBS1 NUP62 NUP214 POM121C PICALM TP53BP2 | 1.06e-05 | 444 | 64 | 9 | int:SYNE3 |
| Interaction | SEH1L interactions | 1.09e-05 | 158 | 64 | 6 | int:SEH1L | |
| Interaction | NUP43 interactions | SZT2 MCM3AP NSD1 NUP62 NUP214 ZBTB11 POM121C MGA TRIP12 NUP153 | 2.56e-05 | 625 | 64 | 10 | int:NUP43 |
| Interaction | SFN interactions | TBC1D4 TEX2 PHF3 SIPA1L1 NUMB SORBS1 TRIP12 USP6NL TP53BP2 SH3BP4 | 6.06e-05 | 692 | 64 | 10 | int:SFN |
| Interaction | DPPA3 interactions | 6.10e-05 | 67 | 64 | 4 | int:DPPA3 | |
| Interaction | YWHAB interactions | TBC1D4 PHF3 SIPA1L1 NUMB SORBS1 PPIP5K2 TRRAP TRIP12 USP6NL WWC1 TP53BP2 SH3BP4 | 7.17e-05 | 1014 | 64 | 12 | int:YWHAB |
| Interaction | STAMBPL1 interactions | 9.49e-05 | 75 | 64 | 4 | int:STAMBPL1 | |
| Interaction | PHF21A interactions | 1.05e-04 | 343 | 64 | 7 | int:PHF21A | |
| GeneFamily | CD molecules|Mucins | 1.20e-07 | 21 | 40 | 4 | 648 | |
| GeneFamily | Nucleoporins | 4.76e-05 | 32 | 40 | 3 | 1051 | |
| GeneFamily | Lysine acetyltransferases|ATAC complex|SAGA complex|GCN5 related N-acetyltransferases | 6.36e-04 | 17 | 40 | 2 | 1059 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 6.36e-04 | 17 | 40 | 2 | 1291 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.09e-03 | 206 | 40 | 4 | 682 | |
| GeneFamily | ArfGAPs | 2.41e-03 | 33 | 40 | 2 | 395 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 5.47e-03 | 50 | 40 | 2 | 721 | |
| GeneFamily | Ankyrin repeat domain containing | 1.63e-02 | 242 | 40 | 3 | 403 | |
| GeneFamily | PHD finger proteins | 1.69e-02 | 90 | 40 | 2 | 88 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ASXL1 DLC1 PHF3 SIPA1L1 NUMB ATP13A3 PPIP5K2 ZBTB11 ZZEF1 TRRAP TRIP12 PICALM NUP153 WWC1 MRTFA TP53BP2 | 1.64e-10 | 856 | 64 | 16 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | DLC1 PHF3 NUMB ATP13A3 TRRAP TRIP12 PICALM NUP153 WWC1 TP53BP2 | 1.84e-07 | 466 | 64 | 10 | M13522 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 6.81e-07 | 300 | 64 | 8 | M8702 | |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | 2.80e-05 | 498 | 64 | 8 | M1741 | |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | 3.17e-05 | 507 | 64 | 8 | MM1030 | |
| Coexpression | GSE6269_FLU_VS_E_COLI_INF_PBMC_UP | 5.11e-05 | 164 | 64 | 5 | M5653 | |
| Coexpression | GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN | 8.80e-05 | 184 | 64 | 5 | M19988 | |
| Coexpression | GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP | 1.18e-04 | 196 | 64 | 5 | M4244 | |
| Coexpression | GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP | 1.27e-04 | 199 | 64 | 5 | M9850 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN | 1.30e-04 | 200 | 64 | 5 | M9472 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP | 1.30e-04 | 200 | 64 | 5 | M9495 | |
| Coexpression | GSE14308_TH2_VS_NAIVE_CD4_TCELL_DN | 1.30e-04 | 200 | 64 | 5 | M3365 | |
| Coexpression | GSE27786_BCELL_VS_NKCELL_UP | 1.30e-04 | 200 | 64 | 5 | M4805 | |
| Coexpression | GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP | 1.30e-04 | 200 | 64 | 5 | M9030 | |
| Coexpression | GSE21380_NON_TFH_VS_TFH_CD4_TCELL_DN | 1.30e-04 | 200 | 64 | 5 | M7502 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_200 | 1.05e-07 | 78 | 62 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_200_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#3_top-relative-expression-ranked_100 | 2.86e-06 | 34 | 62 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_100_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#1_top-relative-expression-ranked_500 | 4.87e-06 | 231 | 62 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_200 | 1.06e-05 | 171 | 62 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.15e-05 | 369 | 62 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000 | CEP68 TCF4 TBC1D4 SZT2 TLE2 SIPA1L1 VCAN ATP13A3 NUP214 ARHGAP39 WNK4 | 1.39e-05 | 779 | 62 | 11 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.95e-05 | 397 | 62 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 2.16e-05 | 194 | 62 | 6 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | kidney_e13.5_Podocyte_MafB_k-means-cluster#4_top-relative-expression-ranked_200 | 4.03e-05 | 23 | 62 | 3 | gudmap_kidney_e13.5_Podocyte_MafB_k4_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_100 | 1.02e-04 | 83 | 62 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | 1.06e-04 | 806 | 62 | 10 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.15e-04 | 379 | 62 | 7 | gudmap_developingKidney_e15.5_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_500 | 1.21e-04 | 165 | 62 | 5 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_500 | 1.63e-04 | 401 | 62 | 7 | gudmap_developingKidney_e15.5_Cap mesenchyme_500 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_200 | 1.72e-04 | 37 | 62 | 3 | gudmap_kidney_P1_CapMes_Crym_k2_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | 1.82e-04 | 408 | 62 | 7 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_500 | 2.20e-04 | 421 | 62 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.95e-04 | 312 | 62 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500 | 3.61e-04 | 209 | 62 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.98e-04 | 330 | 62 | 6 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | 4.73e-04 | 795 | 62 | 9 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | 5.23e-04 | 806 | 62 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.51e-07 | 193 | 64 | 6 | dbf0fe496254320c894568c31e5f9ce63707d1b5 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.63e-06 | 177 | 64 | 5 | a4c001a8e44142babf9f24dfe6f7b73a70b11b16 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.63e-06 | 177 | 64 | 5 | 363e07b0f347f3716d530a28ead854b98e27d37c | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 6.44e-06 | 182 | 64 | 5 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 6.79e-06 | 184 | 64 | 5 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 7.74e-06 | 189 | 64 | 5 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 7.94e-06 | 190 | 64 | 5 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.94e-06 | 190 | 64 | 5 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 7.94e-06 | 190 | 64 | 5 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.35e-06 | 192 | 64 | 5 | 3f925a80b5e2b0577d573e88598a2984a5f6a789 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.56e-06 | 193 | 64 | 5 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 8.56e-06 | 193 | 64 | 5 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 8.78e-06 | 194 | 64 | 5 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 9.00e-06 | 195 | 64 | 5 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 9.00e-06 | 195 | 64 | 5 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Epithelial_cells-Club_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 9.00e-06 | 195 | 64 | 5 | b758676abfc4e6930b696d270ecc0ea461b87a54 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.69e-06 | 198 | 64 | 5 | af07a970afaa435c6433bb5c1cbff4c67af350c7 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Mucous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.93e-06 | 199 | 64 | 5 | f37114cf849837fdb8ed9a767de773e8681b7df3 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-05 | 200 | 64 | 5 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-05 | 200 | 64 | 5 | 85c0f038bcfb42669dca2b80273b0f8a1421405e | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.88e-05 | 122 | 64 | 4 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.29e-05 | 160 | 64 | 4 | 028b5261a1da832d52f66fb620db83e5fbbd874a | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.29e-05 | 160 | 64 | 4 | 1f4ee446436726c3d373f56d87dd80b6a12e8b9e | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 8.70e-05 | 162 | 64 | 4 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D175|Adult / Lineage, Cell type, age group and donor | 9.12e-05 | 164 | 64 | 4 | 6e6aedb61f8e195d52e028fdda750a29bb14e57e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.78e-05 | 167 | 64 | 4 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.05e-04 | 170 | 64 | 4 | cc66ac6846c58be9493eb270644ee3ce0f86cfea | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.15e-04 | 174 | 64 | 4 | 7fb7bdf62563f2102fb38618b503eb2817b6594f | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.15e-04 | 174 | 64 | 4 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.17e-04 | 175 | 64 | 4 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.20e-04 | 176 | 64 | 4 | 77516048aefbe1f48e825052756df0c310c1c486 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 178 | 64 | 4 | 4df6218b20c2f076c22346d23260964cc0d73e65 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-04 | 179 | 64 | 4 | e6ae070b4c52ba08167c7d64ea4cfbac0454c1bf | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.31e-04 | 180 | 64 | 4 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-04 | 181 | 64 | 4 | 30729f0364f719c044712a51453e22dc2c1a232b | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.36e-04 | 182 | 64 | 4 | e67f3234165199085c793915ebb1f9bbd845e933 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.36e-04 | 182 | 64 | 4 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 182 | 64 | 4 | edfc598b7199ca1d8a399b264ab863c299b1eede | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.39e-04 | 183 | 64 | 4 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 1.39e-04 | 183 | 64 | 4 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | COVID-19-kidney-CD-IC-A|kidney / Disease (COVID-19 only), tissue and cell type | 1.39e-04 | 183 | 64 | 4 | 5c7597a5b2bf6a481ca2c7e68560179214150fa0 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.42e-04 | 184 | 64 | 4 | 857ca1fc4de07b300839b22924211dc624453841 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.42e-04 | 184 | 64 | 4 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.42e-04 | 184 | 64 | 4 | 01c19a830348ab0b9c02c1546a439de70ee10f97 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.45e-04 | 185 | 64 | 4 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | Control-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 1.45e-04 | 185 | 64 | 4 | e481cacda0b6b25f5f0062b962df9a442053ac30 | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.45e-04 | 185 | 64 | 4 | 1bbc2ba8a20f72f61981b1301cdd6018cdd9150d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.45e-04 | 185 | 64 | 4 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.45e-04 | 185 | 64 | 4 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | (5)_Epithelial_cells-(5)_Glands_duct|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.48e-04 | 186 | 64 | 4 | 219b1aeca17503244fabbb780bca58f22c7c0f27 | |
| ToppCell | (5)_Glands_duct|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.48e-04 | 186 | 64 | 4 | ad8d5010e5095508f4995e0c6c016a44e8ffb8dd | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 186 | 64 | 4 | a6ef5d5944af5689b5f27bef89cd05645eedbe50 | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.48e-04 | 186 | 64 | 4 | 916f2aeea4989ba7a29e071e348a51010f010223 | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic-pDC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.48e-04 | 186 | 64 | 4 | 45f66619e45d590c7365a51782d4ac46b7d31fde | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.51e-04 | 187 | 64 | 4 | 173f029dcf32af008f517912f6d110a33a9e98cf | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.51e-04 | 187 | 64 | 4 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.54e-04 | 188 | 64 | 4 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 188 | 64 | 4 | e751cff2ac8fbc1487766c1871fcc5d1005286b0 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.57e-04 | 189 | 64 | 4 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.57e-04 | 189 | 64 | 4 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.61e-04 | 190 | 64 | 4 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.61e-04 | 190 | 64 | 4 | 23f2ac4da431211084bb6ab0494c2e0b69547cb6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-04 | 190 | 64 | 4 | 5681c211baeed4af82a2bbc13420f6a7b487581c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.61e-04 | 190 | 64 | 4 | 3c337374d89e69cc0a78e65a4a7e21db7b050fcd | |
| ToppCell | COPD-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 1.64e-04 | 191 | 64 | 4 | 3ae18bc4e3dff49b5d5958da8ebc3f747274b69c | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-SMG_Basal/Duct|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.64e-04 | 191 | 64 | 4 | 30e7cc5f7eadf90ab0900a73fdfe48f9a1adcbfb | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-SMG_Basal/Duct-SMG_Basal/Duct|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.64e-04 | 191 | 64 | 4 | 41d2f5278f6d5f52a5bdf4f3df70969481c00162 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.64e-04 | 191 | 64 | 4 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 191 | 64 | 4 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 191 | 64 | 4 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.67e-04 | 192 | 64 | 4 | c227ab1914191e839fc39c9adc2080026d4b04fc | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.67e-04 | 192 | 64 | 4 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct-SMG_duct_L.0.6.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.67e-04 | 192 | 64 | 4 | bf187a57a559ab732bb815892af45ca922966ac6 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.67e-04 | 192 | 64 | 4 | f573b2d205bd4d053a548af3fe3ff9de7be0cd2b | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.67e-04 | 192 | 64 | 4 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 192 | 64 | 4 | f7e7491426bbd6ed29a465b58bf67acb93dbb90a | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.67e-04 | 192 | 64 | 4 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.67e-04 | 192 | 64 | 4 | 6bba80887d6f64cf913a5c22f62baaddda417ce0 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-04 | 192 | 64 | 4 | d0fb6885f023d55a2b7984c99db9c6463258f788 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.71e-04 | 193 | 64 | 4 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-04 | 193 | 64 | 4 | 0256e8fe4a47f2e2a43ef9d19bfc047d20806d69 | |
| ToppCell | CF-Lymphoid|CF / Disease state, Lineage and Cell class | 1.71e-04 | 193 | 64 | 4 | 11de07d13a7da223990b56fa89ba7fc1c3dd0122 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 1.74e-04 | 194 | 64 | 4 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 1.74e-04 | 194 | 64 | 4 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 194 | 64 | 4 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 195 | 64 | 4 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.77e-04 | 195 | 64 | 4 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.77e-04 | 195 | 64 | 4 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.77e-04 | 195 | 64 | 4 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 195 | 64 | 4 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.77e-04 | 195 | 64 | 4 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.77e-04 | 195 | 64 | 4 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.81e-04 | 196 | 64 | 4 | a7adc0e0baef261d0937e4e8351321d41beca82f | |
| ToppCell | COVID-19-Myeloid-Monocytes|COVID-19 / group, cell type (main and fine annotations) | 1.81e-04 | 196 | 64 | 4 | 04d710267658ea5601ae2cfb4ed5acb8a29bd8a1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-04 | 196 | 64 | 4 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-04 | 196 | 64 | 4 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn|World / Primary Cells by Cluster | 1.81e-04 | 196 | 64 | 4 | 9401bd84798f0ea3e986e94135a9e1dc5643330f | |
| ToppCell | tumor_Lung-Myeloid_cells-Monocytes|tumor_Lung / Location, Cell class and cell subclass | 1.81e-04 | 196 | 64 | 4 | 4a00c416688ae06ed2aef19626a485f646925d67 | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.84e-04 | 197 | 64 | 4 | 6806ec223e542f0475303698eb78c1cc527f5c6b | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.84e-04 | 197 | 64 | 4 | e14a0e8a893c72356afc5508e3531ae0b23bfe16 | |
| Drug | Hydroflumethiazide [135-09-1]; Up 200; 12uM; MCF7; HT_HG-U133A | 1.16e-06 | 196 | 63 | 7 | 1687_UP | |
| Drug | Althiazide [5588-16-9]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.20e-06 | 197 | 63 | 7 | 6829_UP | |
| Drug | Nitrendipine [39562-70-4]; Up 200; 11uM; HL60; HT_HG-U133A | 1.52e-05 | 192 | 63 | 6 | 3087_UP | |
| Drug | Clonidine hydrochloride [4205-91-8]; Up 200; 15uM; PC3; HT_HG-U133A | 1.75e-05 | 197 | 63 | 6 | 4478_UP | |
| Drug | (S)-(-)-Atenolol [93379-54-5]; Down 200; 15uM; PC3; HT_HG-U133A | 1.80e-05 | 198 | 63 | 6 | 6725_DN | |
| Drug | Nialamide [51-12-7]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.80e-05 | 198 | 63 | 6 | 4525_UP | |
| Drug | Sulpiride [15676-16-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.86e-05 | 199 | 63 | 6 | 4389_UP | |
| Drug | titanium silicate | 4.51e-05 | 4 | 63 | 2 | CID011600682 | |
| Drug | Nexus | 6.39e-05 | 152 | 63 | 5 | CID000098527 | |
| Drug | Methylergometrine maleate [113-42-8]; Up 200; 8.8uM; HL60; HG-U133A | 9.97e-05 | 167 | 63 | 5 | 1607_UP | |
| Drug | trifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 1.53e-04 | 183 | 63 | 5 | 5221_UP | |
| Drug | Rifabutin [72559-06-9]; Up 200; 4.8uM; PC3; HT_HG-U133A | 1.57e-04 | 184 | 63 | 5 | 4527_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 1.65e-04 | 186 | 63 | 5 | 6671_UP | |
| Drug | Tadjakonine [11087-94-8]; Up 200; 7.4uM; PC3; HT_HG-U133A | 2.01e-04 | 194 | 63 | 5 | 4599_UP | |
| Drug | Ergocryptine-alpha [511-09-1]; Up 200; 7uM; PC3; HT_HG-U133A | 2.01e-04 | 194 | 63 | 5 | 4552_UP | |
| Drug | Niridazole [61-57-4]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 2.01e-04 | 194 | 63 | 5 | 3301_UP | |
| Drug | Naringenine [480-41-1]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 2.01e-04 | 194 | 63 | 5 | 4422_DN | |
| Drug | phentolamine; Down 200; 11.5uM; MCF7; HT_HG-U133A_EA | 2.06e-04 | 195 | 63 | 5 | 1138_DN | |
| Drug | 3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; PC3; HT_HG-U133A | 2.06e-04 | 195 | 63 | 5 | 4664_DN | |
| Drug | Oxamniquine [21738-42-1]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 2.06e-04 | 195 | 63 | 5 | 4124_UP | |
| Drug | Vancomycin hydrochloride [1404-93-9]; Down 200; 2.6uM; MCF7; HT_HG-U133A | 2.11e-04 | 196 | 63 | 5 | 4423_DN | |
| Drug | Molindone hydrochloride [15622-65-8]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 2.11e-04 | 196 | 63 | 5 | 4784_UP | |
| Drug | Cefoxitin sodium salt [33564-30-6]; Up 200; 8.8uM; HL60; HT_HG-U133A | 2.11e-04 | 196 | 63 | 5 | 2735_UP | |
| Drug | Guanethidine sulfate [60-02-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 2.11e-04 | 196 | 63 | 5 | 3171_UP | |
| Drug | Betamethasone [378-44-9]; Down 200; 10.2uM; PC3; HT_HG-U133A | 2.11e-04 | 196 | 63 | 5 | 6728_DN | |
| Drug | Epicatechin-(-) [154-23-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 2.11e-04 | 196 | 63 | 5 | 4419_DN | |
| Drug | Sisomicin sulfate [53179-09-2]; Down 200; 2.8uM; HL60; HT_HG-U133A | 2.11e-04 | 196 | 63 | 5 | 2493_DN | |
| Drug | 0173570-0000 [211245-44-2]; Up 200; 1uM; MCF7; HT_HG-U133A | 2.16e-04 | 197 | 63 | 5 | 4715_UP | |
| Drug | Ethisterone [434-03-7]; Up 200; 12.8uM; HL60; HT_HG-U133A | 2.16e-04 | 197 | 63 | 5 | 2366_UP | |
| Drug | deferoxamine mesylate salt; Down 200; 100uM; PC3; HG-U133A | 2.16e-04 | 197 | 63 | 5 | 460_DN | |
| Drug | Amidopyrine [58-15-1]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 2.16e-04 | 197 | 63 | 5 | 2222_UP | |
| Drug | Sulfadiazine [68-35-9]; Up 200; 16uM; PC3; HT_HG-U133A | 2.16e-04 | 197 | 63 | 5 | 5098_UP | |
| Drug | ICI 182,780; Up 200; 0.01uM; HL60; HT_HG-U133A | 2.16e-04 | 197 | 63 | 5 | 2698_UP | |
| Drug | 5155877; Down 200; 10uM; MCF7; HT_HG-U133A | 2.16e-04 | 197 | 63 | 5 | 6549_DN | |
| Drug | Vancomycin hydrochloride [1404-93-9]; Up 200; 2.6uM; PC3; HT_HG-U133A | 2.16e-04 | 197 | 63 | 5 | 4598_UP | |
| Drug | Cyclopentolate hydrochloride [5870-29-1]; Up 200; 12.2uM; PC3; HT_HG-U133A | 2.16e-04 | 197 | 63 | 5 | 5734_UP | |
| Drug | Gliclazide [21187-98-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 2.16e-04 | 197 | 63 | 5 | 2870_DN | |
| Drug | Dicloxacillin sodium salt [13412-64-1]; Up 200; 8.2uM; PC3; HT_HG-U133A | 2.16e-04 | 197 | 63 | 5 | 6666_UP | |
| Drug | D-cycloserine [68-41-7]; Up 200; 39.2uM; MCF7; HT_HG-U133A | 2.16e-04 | 197 | 63 | 5 | 3562_UP | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.16e-04 | 197 | 63 | 5 | 5009_UP | |
| Drug | Ethamivan [304-84-7]; Up 200; 18uM; PC3; HT_HG-U133A | 2.16e-04 | 197 | 63 | 5 | 7260_UP | |
| Drug | Proglumide [6620-60-6]; Down 200; 12uM; PC3; HT_HG-U133A | 2.16e-04 | 197 | 63 | 5 | 4337_DN | |
| Drug | Glycopyrrolate [596-51-0]; Down 200; 10uM; HL60; HT_HG-U133A | 2.16e-04 | 197 | 63 | 5 | 2565_DN | |
| Drug | Betonicine [515-25-3]; Up 200; 25.2uM; PC3; HT_HG-U133A | 2.21e-04 | 198 | 63 | 5 | 4301_UP | |
| Drug | estradiol, USP; Up 200; 0.01uM; PC3; HT_HG-U133A | 2.21e-04 | 198 | 63 | 5 | 1241_UP | |
| Drug | Trimethadione [127-48-0]; Down 200; 28uM; HL60; HT_HG-U133A | 2.21e-04 | 198 | 63 | 5 | 2486_DN | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A | 2.21e-04 | 198 | 63 | 5 | 5214_UP | |
| Drug | Methoxamine hydrochloride [61-16-5]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 2.21e-04 | 198 | 63 | 5 | 2848_UP | |
| Drug | Foliosidine [2520-38-9]; Up 200; 13uM; MCF7; HT_HG-U133A | 2.26e-04 | 199 | 63 | 5 | 3636_UP | |
| Drug | Isocarboxazid [59-63-2]; Down 200; 17.2uM; HL60; HT_HG-U133A | 2.26e-04 | 199 | 63 | 5 | 2562_DN | |
| Drug | Budesonide [51333-22-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 2.26e-04 | 199 | 63 | 5 | 2866_UP | |
| Drug | Phenethicillin potassium salt [132-93-4]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.26e-04 | 199 | 63 | 5 | 6105_UP | |
| Drug | Propranolol hydrochloride [318-98-9]; Down 200; 13.6uM; PC3; HT_HG-U133A | 2.26e-04 | 199 | 63 | 5 | 6759_DN | |
| Drug | Mefenamic acid [61-68-7]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 2.26e-04 | 199 | 63 | 5 | 5534_DN | |
| Drug | Desipramine hydrochloride [58-28-6]; Down 200; 13.2uM; PC3; HT_HG-U133A | 2.26e-04 | 199 | 63 | 5 | 6693_DN | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; HL60; HT_HG-U133A | 2.26e-04 | 199 | 63 | 5 | 2677_UP | |
| Drug | Selegiline hydrochloride [14611-52-0]; Up 200; 17.8uM; PC3; HT_HG-U133A | 2.26e-04 | 199 | 63 | 5 | 4065_UP | |
| Drug | Cytisine (-) [485-35-8]; Up 200; 21uM; MCF7; HT_HG-U133A | 2.26e-04 | 199 | 63 | 5 | 6217_UP | |
| Drug | Loxapine succinate [27833-64-3]; Up 200; 9uM; HL60; HG-U133A | 2.31e-04 | 200 | 63 | 5 | 2016_UP | |
| Drug | PHA-00851261E [724719-49-7]; Up 200; 10uM; PC3; HT_HG-U133A | 2.31e-04 | 200 | 63 | 5 | 3773_UP | |
| Disease | cholangiocarcinoma (is_marker_for) | 1.16e-05 | 64 | 64 | 4 | DOID:4947 (is_marker_for) | |
| Disease | STRIATONIGRAL DEGENERATION, INFANTILE (disorder) | 1.39e-05 | 3 | 64 | 2 | C0795996 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 3.41e-05 | 84 | 64 | 4 | DOID:9119 (is_implicated_in) | |
| Disease | cholelithiasis | 4.09e-05 | 88 | 64 | 4 | EFO_0004799 | |
| Disease | cerebral palsy (implicated_via_orthology) | 2.06e-04 | 10 | 64 | 2 | DOID:1969 (implicated_via_orthology) | |
| Disease | Metastatic melanoma | 2.23e-04 | 54 | 64 | 3 | C0278883 | |
| Disease | nucleus accumbens volume change measurement | 2.52e-04 | 11 | 64 | 2 | EFO_0021493 | |
| Disease | Microcephaly | 4.22e-04 | 67 | 64 | 3 | C0025958 | |
| Disease | cutaneous Leishmaniasis | 5.45e-04 | 16 | 64 | 2 | EFO_0005046 | |
| Disease | electroencephalogram measurement | 5.65e-04 | 74 | 64 | 3 | EFO_0004357 | |
| Disease | Acute myeloid leukemia | 6.17e-04 | 17 | 64 | 2 | cv:C0023467 | |
| Disease | LEUKEMIA, ACUTE MYELOID | 6.17e-04 | 17 | 64 | 2 | 601626 | |
| Disease | nose morphology measurement | 7.44e-04 | 329 | 64 | 5 | EFO_0007843 | |
| Disease | carpal tunnel syndrome | 9.68e-04 | 89 | 64 | 3 | EFO_0004143 | |
| Disease | social interaction measurement | 1.13e-03 | 94 | 64 | 3 | EFO_0009592 | |
| Disease | Adenocarcinoma of large intestine | 1.20e-03 | 96 | 64 | 3 | C1319315 | |
| Disease | FEV/FEC ratio | 1.28e-03 | 1228 | 64 | 9 | EFO_0004713 | |
| Disease | Adenoid Cystic Carcinoma | 1.35e-03 | 100 | 64 | 3 | C0010606 | |
| Disease | gallstones | 1.69e-03 | 108 | 64 | 3 | EFO_0004210 | |
| Disease | Ovarian Mucinous Adenocarcinoma | 2.07e-03 | 31 | 64 | 2 | C1335167 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SICFSPSISSTTSPK | 351 | Q96P64 | |
| TFAKLSSQTPSSPLT | 2816 | P13611 | |
| LDSFSVSPASTLKSP | 336 | Q76N32 | |
| FVGTTAFSPLSSKST | 1671 | Q8IZF6 | |
| KPPSSSSSSAKTLAF | 1641 | Q86TB3 | |
| SVASPFTSKTPSISC | 906 | Q9H7F0 | |
| SSSEALFKSFSSAPP | 301 | P42568 | |
| STSSILPFSSSVFPA | 521 | Q9HAK2 | |
| SISSFTFTGPTPFKI | 86 | Q96MT4 | |
| SVPSYPSKSASVTAS | 766 | Q13625 | |
| STSFNYSSSSPTFPK | 1451 | Q8IXJ9 | |
| SICFSPSISSTTSPK | 351 | Q5VW22 | |
| STATKSTATSFTPIP | 3056 | Q9HC84 | |
| STATSFTPIPSFTLG | 3061 | Q9HC84 | |
| TATKSTATSFTPIPS | 4741 | Q9HC84 | |
| SESKFSSSFPKPPSS | 256 | Q9Y5P3 | |
| TSKPSKPLLFSSASS | 881 | Q96L73 | |
| KSSSTPFPFRTGLTS | 251 | Q9H8K7 | |
| SSCVFPTFTLRKPSS | 676 | Q9C0H5 | |
| VFPSSLLPTSSTSLF | 561 | Q9Y2R2 | |
| PLTATEPTSSLATSF | 2651 | Q8WXI7 | |
| TPVSASSSPSKAFAS | 2861 | Q8WXI7 | |
| SSSPSKAFASLTTAP | 2866 | Q8WXI7 | |
| SSFPTDTSFLLSKVP | 5201 | Q8WXI7 | |
| SSPAMTSTSFFSTLP | 8566 | Q8WXI7 | |
| PSSFSTAKTSTSLPY | 1906 | Q6W4X9 | |
| STISPSTSYSLKPHS | 876 | Q8IWI9 | |
| SSSSSLESSSFPLPK | 261 | Q8IX03 | |
| YPSSKPATSTFPSSF | 201 | P15884 | |
| FLVPKSTTSSSAFSP | 1321 | Q5HYC2 | |
| FPTSPTSTAKQEFLT | 2851 | Q2LD37 | |
| SFKSPTSVGAFPSTS | 111 | O60318 | |
| FPSSTATFPETTTLT | 976 | Q02505 | |
| PTAFSPASETTFLKF | 96 | A6NMT0 | |
| TSTPSASGQFSKPFS | 1201 | P35658 | |
| FTFGTAKTATTTPAT | 16 | P37198 | |
| AKTATTTPATGFSFS | 21 | P37198 | |
| PPTSVFSFFPSLSKS | 181 | O15265 | |
| SIPSPTFSKSSSAIS | 701 | Q8IZQ8 | |
| SRSPTAVLTKPSASF | 771 | Q8IZQ8 | |
| TPGFSALTTSSPSIF | 901 | Q8IZQ8 | |
| TSTTAPTFQPVFSSM | 741 | A8CG34 | |
| STPTFNIPFGSSAKS | 921 | A8CG34 | |
| TSASPSTDSASKPAF | 406 | A6NF01 | |
| TPTPSATSFFSGKSP | 601 | P55265 | |
| LLSFSFPAPTSSSEL | 36 | Q7RTS9 | |
| SSFIKTEPSSPASLT | 36 | P62508 | |
| FTKTNSTFSSSPPPV | 1121 | Q4KMG0 | |
| SDFASKPSFLSQPSS | 26 | P31277 | |
| EASSATTSPFFKPPA | 566 | P49757 | |
| LFPPHSTSTKDSFST | 871 | Q5T011 | |
| TSSSFFTGLKSPAPE | 261 | Q9P0V3 | |
| STAPSSLVFTPFASS | 941 | Q5HYW2 | |
| SASPVVFTSARSSPK | 1431 | O43166 | |
| PYSSSKDSSPTLASK | 1726 | O43166 | |
| SFGSLPSPKELSSFS | 636 | Q96QB1 | |
| SLAPLSTTAPSLFST | 901 | Q969V6 | |
| IFSTPSSSNSTSKLP | 376 | Q13492 | |
| FIKSPPSQLFSSVTS | 21 | Q5SXH7 | |
| SSASLTSPLSPFSLV | 696 | Q9Y2H5 | |
| EPSSSPSKVSNKFTF | 591 | Q92738 | |
| LSNFTSSPTTASKPA | 156 | O95625 | |
| FPSVSKPSSAYPSTT | 291 | Q9BX66 | |
| CPSEFPSKSITFTSR | 1771 | Q92576 | |
| SLPITSSSLPTFNFS | 476 | P49790 | |
| SSSLPTFNFSSPEIT | 481 | P49790 | |
| TPFTKPASLFSSSLR | 281 | Q8TEA7 | |
| TSFSAPSFTAPSFLK | 701 | O60343 | |
| SLSPGSTDFSTFLSP | 436 | O43149 | |
| HTPSSKTFSPAFFSL | 331 | Q9C0K7 | |
| TSSPVSPKSLAFTSS | 1011 | O43314 | |
| SSSFIEPIFPTSKIS | 821 | Q6ZXV5 | |
| SPLTSPSDTRSFFKV | 266 | Q8IWB9 | |
| PTTTQSPKSSFLASL | 1031 | Q14669 | |
| SPLTLSSPFTTSFSL | 341 | Q04725 | |
| SSSPKPSSVFRNGFS | 486 | Q7Z4V0 | |
| SIFPTEPSTSSVASK | 2221 | Q9Y4A5 | |
| TFSPTCSQVTLSSPF | 891 | Q96J92 | |
| KDFLNSLSPSTSPTS | 761 | O94782 |